n South African Journal of Psychiatry - Product news

Volume 11, Issue 3
  • ISSN : 1608-9685
  • E-ISSN: 2078-6786
  • Author
  • Source : South African Journal of Psychiatry, Volume 11, Issue 3, Dec 2005, p. 100
  • Accreditation : Department of Higher Education and Training (DHET)
    SciELO SA
    The Sciences Citation Index of the Institute of Scientific Information (ISI)
    The Social Sciences Citation Index of the ISI



Extracted from text ... 100 PAXIL offers quality relief Paxil, a new paroxetine HCl-based psycho-analeptic drug, has been launched into the South African market by GlaxoSmithKline. The schedule-5 drug is indicated for depression, panic disorder with or without agoraphobia, obsessive-compulsive disorder (OCD), social phobia and generalised anxiety disorder (GAD). Navin Singh, medical director at GlaxoSmithKline, says that Paxil is not intended as a replacement for Aropax, which is produced by the same company and will continue to be available, but rather that it should offer an effective, low-cost option for treatment of these conditions. Paroxetine is the only drug of its class currently approved ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error